These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 24424197)

  • 41. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.
    Jarius S; Wildemann B
    Brain Pathol; 2013 Nov; 23(6):661-83. PubMed ID: 24118483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.
    Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Ishii N; Itoyama Y
    Tohoku J Exp Med; 2006 Dec; 210(4):307-13. PubMed ID: 17146196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Devic's neuromyelitis optica: a critical review.
    Lana-Peixoto MA
    Arq Neuropsiquiatr; 2008 Mar; 66(1):120-38. PubMed ID: 18392436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of AQP4 Antibody Serostatus and its Prediction of Visual Outcome in Neuromyelitis Optica: A Systematic Review and Meta-Analysis.
    Lin N; Liu Q; Wang X; Ma J; Li Y
    Protein Pept Lett; 2017; 24(3):245-252. PubMed ID: 28071581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The spectrum of neuromyelitis optica.
    Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG
    Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG
    Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuromyelitis Optica: Review and Utility of Testing Aquaporin-4 Antibody in Typical Optic Neuritis.
    Seay M; Rucker JC
    Asia Pac J Ophthalmol (Phila); 2018; 7(4):229-234. PubMed ID: 29766684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
    Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
    Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y; Wu WP; Huang DH; Wu L
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [NMO spectrum disorders and anti AQP4 antibody].
    Takai Y; Misu T; Takahashi T; Nakashima I; Fujihara K
    Brain Nerve; 2013 Apr; 65(4):333-43. PubMed ID: 23568981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosing neuromyelitis optica.
    Makhani N; Bigi S; Banwell B; Shroff M
    Neuroimaging Clin N Am; 2013 May; 23(2):279-91. PubMed ID: 23608690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
    Jarius S; Paul F; Franciotta D; Waters P; Zipp F; Hohlfeld R; Vincent A; Wildemann B
    Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
    Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
    Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
    Sato DK; Nakashima I; Takahashi T; Misu T; Waters P; Kuroda H; Nishiyama S; Suzuki C; Takai Y; Fujihara K; Itoyama Y; Aoki M
    Neurology; 2013 Jun; 80(24):2210-6. PubMed ID: 23677744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
    Kinoshita M; Nakatsuji Y; Kimura T; Moriya M; Takata K; Okuno T; Kumanogoh A; Kajiyama K; Yoshikawa H; Sakoda S
    Biochem Biophys Res Commun; 2009 Sep; 386(4):623-7. PubMed ID: 19545538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pathogenesis of neuromyelitis optica].
    Misu T; Fujihara K
    Nihon Rinsho; 2013 May; 71(5):823-8. PubMed ID: 23777089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania.
    Sakalauskaitė-Juodeikienė E; Armalienė G; Kizlaitienė R; Bagdonaitė L; Giedraitienė N; Mickevičienė D; Rastenytė D; Kaubrys G; Jatužis D
    Brain Behav; 2018 Nov; 8(11):e01129. PubMed ID: 30284401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evolution of Devic's neuromyelitis optica spectrum disorders].
    Bernard-Valnet R; Marignier R
    Presse Med; 2015 Apr; 44(4 Pt 1):401-10. PubMed ID: 25535163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Seroprevalence and diagnostic value of aquaporin-4 antibody in patients with inflammatory central nervous system demyelinating diseases].
    Wu L; Yang Y; Huang DH; Wu WP
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):350-2. PubMed ID: 21354891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.